Perioperative Complications
Conditions
Brief summary
1. To establish a risk assessment scale for thoracic surgery for the Chinese population, and to classify patients; risk according to the relevant scale; 2. Combining the guidelines for the management of acute and critical illnesses in thoracic surgical care units and the characteristics of diagnosis and treatment operations, to make an AI-assisted diagnosis and treatment process software; 3. Evaluate whether the software can provide timely and correct diagnosis and treatment recommendations for critically ill patients, shorten the time for homogenized training of specialist intensivists, and reduce the hospitalization cost of patients under the review of resident training instructors of various specialties.
Interventions
OTHERObservation
Observation
Sponsors
Changsha Xinghong Network Technology Co.
Hengxing Liang
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients admitted to the Department of Thoracic Surgery of the Second Xiangya Hospital of Central South University for surgical treatment.
Exclusion criteria
* Patients admitted to the Department of Thoracic Surgery of the Second Xiangya Hospital of Central South University without surgical treatment. Patients under the age of 18.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Acute Respiratory Distress Syndrome | 2024.8-2024.12 | ARDS definition was based on the new global definition of ARDS10. Briefly, intubated ARDS was defined as an oxygenation index of less than 300 under a positive end-expiratory pressure (PEEP) of at least 5 cmH2O, and non-intubated ARDS was defined as patients receiving high-flow nasal oxygen (HFNO) ≥ 30 L/min or noninvasive ventilation/continuous positive airway pressure (NIV/CPAP) with a PEEP of at least 5 cmH2O and meeting PaO2:FiO2 ≤ 300 mm Hg or SpO2:FiO2 ≤ 315 (if SpO2 ≤ 97%). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Length of hospital stay | 2024.8-2024.12 | Length of hospital stay(days): refers to the total number of days a patient spends in the hospital from the time of admission to the time of discharge. |
| Length of ICU stay | 2024.8-2024.12 | Length of ICU stay(hours): refers to the total duration of time a patient spends in the Intensive Care Unit (ICU) during a single admission. |
| In hospital mortality | 2024.8-2024.12 | refers to the number or percentage of patients who die while being treated in a hospital. |
| Duration of mechanical ventilation | 2024.8-2024.12 | Duration of mechanical ventilation(hours): refers to the length of time a patient requires assistance from a mechanical ventilator to maintain adequate breathing. |
| Duration of HFNC | 2024.8-2024.12 | Duration of HFNC(hours): refers to the length of time that a patient is treated with High-Flow Nasal Cannula (HFNC) therapy. |
| Length of postoperative stay | 2024.8-2024.12 | Length of postoperative stay(days): refers to the duration of time a patient remains in the hospital or medical facility after undergoing surgery. |
Countries
China
Outcome results
None listed